Victor Wembanyama Likely to Miss Remainder of Season After Blood Clot Diagnosis, Spurs Announce
San Antonio Spurs star Victor Wembanyama’s season is expected to end prematurely after being diagnosed with a blood clot in his right shoulder. This significant health issue not only sidelines one of the NBA’s brightest young stars but also marks the second major setback for the Spurs in just a few months.
Wembanyama’s Diagnosis and Treatment Plan
The 7-foot-3 French center, who is leading the NBA in shot-blocking, is now undergoing immediate treatment for his condition, deep vein thrombosis (DVT). The Spurs remain optimistic about his full recovery, with a source close to the situation confirming that the team is working under the expectation that Wembanyama will return to full health.
There is a possibility that Wembanyama could represent France in the European Championships this summer, should he choose to participate, according to the source. The diagnosis came just after Wembanyama’s appearance at the All-Star Game, where he was named a first-time All-Star.
Impact on the Team
Spurs guard Chris Paul expressed the team’s deep disappointment, both for the loss of Wembanyama’s on-court presence and his leadership in the locker room. “You can’t replace Vic,” Paul said. “I can’t stand on a guy’s shoulders and block every shot that comes to the rim. Aside from his basketball ability, his charisma and what he brings into the locker room, I think, is what we’ll miss the most.”
The Timing of Wembanyama’s Diagnosis
The diagnosis comes just over three months after Spurs head coach Gregg Popovich suffered a stroke, which forced him to step away from coaching duties. Since then, assistant coach Mitch Johnson has taken over as interim head coach. While Popovich’s health is reportedly improving, there is still no clear timeline for his return to the bench.
Chris Paul acknowledged the difficult period for the organization, saying, “It’s been extremely tough. We know we’ve got a job to do, but like anybody, we worry about our people.”
Wembanyama’s Remarkable Season Cut Short
Wembanyama, the 2023 NBA Rookie of the Year and the frontrunner for Defensive Player of the Year this season, has been a standout on both ends of the floor. He’s already attempted 403 three-pointers and blocked 176 shots, both of which are historic numbers for a player at this stage in their career. His averages of 24.3 points, 11 rebounds, 3.8 blocks, and 3.7 assists put him in rare company, alongside NBA legends like Kareem Abdul-Jabbar.
The Spurs are set to resume their post-All-Star break schedule against the Phoenix Suns later Thursday in Austin, Texas. Wembanyama had been listed as doubtful for the game due to illness before the blood clot diagnosis was revealed.
Reactions from Around the League
The news of Wembanyama’s diagnosis shocked many, including Miami Heat forward Kevin Love, who expressed his disbelief and concern: “First of all, you pray for him. You hope for the best, personally and professionally. He means so much to the league. He’s an incredible competitor and has the potential to be the face of the league for the next 20 years.”
The NBA has seen similar cases in the past, such as Hall of Famer Chris Bosh, whose career was cut short by blood clots while playing for Miami, and Brandon Ingram, who missed part of the 2018-19 season due to a similar condition. Detroit Pistons’ Ausar Thompson also dealt with a blood clot issue that affected the end of his 2023-24 season.
Medical Questions and Long-Term Outlook
The primary concern for the Spurs’ medical team now is to understand why Wembanyama developed the blood clot. Dr. Geoffrey Barnes, an associate professor of cardiology at the University of Michigan, explained the importance of determining the cause: “Any time we have upper extremity or arm blood clots, we need to ask ourselves why they happened. It’s important to understand why this occurred because it will guide treatment and help predict the long-term consequences.”
While Wembanyama’s health situation is concerning, there is hope for recovery. Many athletes have successfully returned to competition after similar diagnoses, including tennis legend Serena Williams, who came back to dominate after being diagnosed with a pulmonary embolism in 2011.
Looking Ahead
Wembanyama, the No. 1 pick in the 2023 NBA Draft, was poised to continue his rise as one of the most exciting players in the league. His remarkable performance on the court, including his leadership in France’s silver medal finish at the 2024 Paris Olympics, made him a global basketball sensation. Now, as the Spurs navigate this difficult period, the basketball world awaits his return to full health and future contributions to the game.
In the meantime, Chris Paul reflects on the emotional toll: “It’s tough. It’s tough more than anything, knowing how much he means to our team and to the game. But more than that, knowing how much he loves to play.”
This article was rewritten and editorially reviewed by Journos News based on verified reporting from trusted sources. All content is independently fact-checked and edited for accuracy, neutrality, tone, and global readability in line with Google News and AdSense publishing standards.
Opinions, quotes, and statements from contributors, experts, or cited organizations do not necessarily reflect the views of Journos News. The newsroom maintains full editorial independence from external funders, sponsors, and affiliated entities.
